• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Bright Health Group Appoints Jay Matushak as Chief Financial Officer

    5/3/23 5:00:00 PM ET
    $BHG
    Medical Specialities
    Health Care
    Get the next $BHG alert in real time by email

    Cathy Smith to Step Down to Pursue New Opportunity, Effective May 12, 2023

    Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced that it has appointed Jay Matushak as the Company's next Chief Financial Officer, effective May 12, 2023. Mr. Matushak will succeed Cathy Smith, who is stepping down to pursue another opportunity.

    Mr. Matushak, a seasoned finance and operational executive with deep expertise in the healthcare business, joined Bright Health in 2021. He currently serves as Senior Vice President of Finance and is responsible for the wind-down of the Company's ACA insurance business. He also serves as CFO of Bright HealthCare, the Company's insurance business. Before joining Bright Health, Mr. Matushak served for six years as CFO of Blue Cross Blue Shield of Minnesota (BCBS MN). Prior to BCBS MN, he spent fifteen years at UnitedHealth Group in various financial leadership roles within Optum and UnitedHealthcare.

    "Jay has deep knowledge of our business and a strong track record of financial leadership across the healthcare industry," said Mike Mikan, President and CEO of Bright Health. "He is a proven leader, and he will play an important role in our continuing efforts to position Bright Health for long-term success."

    "I am honored to take on this role and work alongside the leadership team and talented finance team to execute on our financial and strategic priorities," said Mr. Matushak. "I am confident in the tremendous opportunities ahead as we take action to ensure Bright Health is poised for future profitable growth."

    Mr. Mikan continued, "Cathy was integral in helping take Bright Health public, and we thank her for the many contributions she has made to the Company. She has been a valuable member of our leadership team and built a strong organization with a deep bench of talent, which will help ensure a smooth succession. On behalf of everyone at Bright Health, we wish Cathy all the best in her next chapter."

    Ms. Smith will continue in her role through the Company's first quarter 2023 earnings and thereafter will serve in an advisory role to support a smooth transition. Ms. Smith's decision to resign was not due to any conflicts with the Board or management team regarding the Company's financial reporting or accounting principles or practices.

    About Bright Health Group

    Bright Health Group is a technology enabled, value-driven healthcare company that organizes and operates networks of affiliate care providers to be successful at managing population risk. We focus on serving aging and underserved consumers that have unmet clinical needs through our Fully Aligned Care Model in Florida, Texas and California, some of the largest markets in healthcare where 26% of the U.S. aging population call home. We believe everyone should have access to personal, affordable, and high-quality healthcare. Our mission is to Make healthcare right. Together. For more information, visit www.brighthealthgroup.com.

    Forward-Looking Statements

    Statements made in this release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as "anticipate," "expect," "plan," "believe," "intend," "project," "forecast," "estimates," "projections," "outlook," "ensure," and other similar expressions. These forward-looking statements include any statements regarding our plans and expectations with respect to Bright Health Group, Inc. Such forward-looking statements are subject to various risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. Factors that might materially affect such forward-looking statements include: our ability to continue as a going concern; our ability to comply with the terms of our credit facility, including financial covenants, both during and after any waiver period, and/or obtain any additional waivers of any terms of our credit facility to the extent required; our ability to sell our Medicare Advantage business in California on acceptable terms, including our ability to receive the proceeds thereof in a manner that would alleviate our current financial position; our ability to quickly and efficiently wind down our IFP businesses and MA businesses outside of California; potential disruptions to our business due to our corporate restructuring and resulting headcount reduction; our ability to accurately estimate and effectively manage the costs relating to changes in our businesses offerings and models; a delay or inability to withdraw regulated capital from our subsidiaries; a lack of acceptance or slow adoption of our business model; our ability to retain existing consumers and expand consumer enrollment; our and our Care Partner's abilities to obtain and accurately assess, code, and report risk adjustment factor scores; our ability to contract with care providers and arrange for the provision of quality care; our ability to accurately estimate our medical expenses, effectively manage our costs and claims liabilities or appropriately price our products and charge premiums; our ability to obtain claims information timely and accurately; the impact of the ongoing COVID-19 pandemic on our business and results of operations; the risks associated with our reliance on third-party providers to operate our business; the impact of modifications or changes to the U.S. health insurance markets; our ability to manage the growth of our business; our ability to operate, update or implement our technology platform and other information technology systems; our ability to retain key executives; our ability to successfully pursue acquisitions and integrate acquired businesses; the occurrence of severe weather events, catastrophic health events, natural or man-made disasters, and social and political conditions or civil unrest; our ability to prevent and contain data security incidents and the impact of data security incidents on our members, patients, employees and financial results; our ability to comply with requirements to maintain effective internal controls; our ability to adapt to the new risks associated with our expansion into ACO Reach; and the other factors set forth under the heading "Risk Factors" in the Company's reports on Form 10-K, Form 10-Q, and Form 8-K (including all amendments to those reports) and our other filings with the SEC. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this release to conform these statements to actual results or changes in our expectations.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230503005935/en/

    Get the next $BHG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BHG

    DatePrice TargetRatingAnalyst
    10/11/2022Neutral → Underweight
    JP Morgan
    3/29/2022Overweight → Neutral
    JP Morgan
    3/4/2022$9.00 → $3.00Outperform → Sector Perform
    RBC Capital
    3/3/2022$4.00 → $2.00Underweight
    Morgan Stanley
    3/3/2022$5.00 → $3.50Neutral
    Goldman Sachs
    3/3/2022$5.50 → $4.00Overweight
    Barclays
    3/3/2022$10.00 → $5.00Overweight
    Piper Sandler
    3/2/2022Buy → Underperform
    BofA Securities
    More analyst ratings

    $BHG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Yang Rick

      4 - Bright Health Group Inc. (0001671284) (Issuer)

      12/21/23 5:05:33 PM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Walker Paul Edward

      4 - Bright Health Group Inc. (0001671284) (Issuer)

      12/21/23 5:04:41 PM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Sandell Scott D

      4 - Bright Health Group Inc. (0001671284) (Issuer)

      12/21/23 5:02:52 PM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bright Health Group downgraded by JP Morgan

      JP Morgan downgraded Bright Health Group from Neutral to Underweight

      10/11/22 12:28:36 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group downgraded by JP Morgan

      JP Morgan downgraded Bright Health Group from Overweight to Neutral

      3/29/22 7:08:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Gr downgraded by RBC Capital with a new price target

      RBC Capital downgraded Bright Health Gr from Outperform to Sector Perform and set a new price target of $3.00 from $9.00 previously

      3/4/22 6:06:15 AM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $BHG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $BHG
    Financials

    Live finance-specific insights

    See more
    • Bright Health Group Adopts NeueHealth as Corporate Brand Name

      The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement services Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company's common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock

      1/17/24 4:05:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Closes the Sale of its California Medicare Advantage Business to Molina Healthcare

      Completes final repayment on secured credit facility eliminating the Company's secured debt Further focuses on increasing access to value-driven healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid through its continuing business, NeueHealth Reaffirms expectation for Adjusted EBITDA profitability in 2024 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it has successfully completed the sale of its California Medicare Advantage business, Brand New Day and Central Health Plan, to Molina Healthcare, Inc. ("Molina"). The sale closed, effective as of Januar

      1/2/24 4:30:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

      Received all required regulatory approvals on the sale of the California Medicare Advantage business; the transaction is expected to close on or about January 1, 2024 Amended Company's secured credit facility to reduce the final repayment resulting in approximately $30 million in savings Meaningfully improves capital position to support continuing business, NeueHealth, a value-driven consumer care delivery and provider enablement business Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into an amendment to its credit facility with J.P. Morgan that will reduce the final

      12/29/23 6:45:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Bright Health Group Inc. (Amendment)

      SC 13G/A - NeueHealth, Inc. (0001671284) (Subject)

      2/14/24 5:04:52 PM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by Bright Health Group Inc. (Amendment)

      SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

      2/14/24 9:37:57 AM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by Bright Health Group Inc. (Amendment)

      SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

      12/22/23 4:34:44 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Reports Third Quarter 2023 Results

      Q3'23 Revenue from Continuing Business of $269.4 million, up 39% year over year Value-Based Consumers served of 355,000, an increase of 208.7% on a comparable basis from last year on strong growth in Care Delivery Q3'23 Net Loss from Continuing Business of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge; Positive Adjusted EBITDA of $1.2 million in Q3'23 Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial r

      11/7/23 6:45:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group to Host Third Quarter 2023 Earnings Conference Call on November 7, 2023

      Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthe

      10/13/23 8:00:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Reports Second Quarter 2023 Results

      Q2'23 Revenue from Continuing Business of $298.0 million, up 100% year over year Value-Based Consumers served of 371,000, an increase of 214% on a comparable basis from last year on strong growth in Care Delivery Q2'23 Net Loss from Continuing Business of $31.7 million; Positive Adjusted EBITDA of $6.4 million in Q2'23, positive Operating Income in Care Delivery and Care Solutions segments Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported fi

      8/9/23 6:45:00 AM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    SEC Filings

    See more
    • Bright Health Group Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Bright Health Group Inc. (0001671284) (Filer)

      1/24/24 5:09:44 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Inc. filed SEC Form 8-K: Financial Statements and Exhibits

      8-K - Bright Health Group Inc. (0001671284) (Filer)

      1/4/24 9:17:32 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Bright Health Group Inc. (0001671284) (Filer)

      1/2/24 4:32:58 PM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Leadership Updates

    Live Leadership Updates

    See more
    • Bright Health Group Appoints Jay Matushak as Chief Financial Officer

      Cathy Smith to Step Down to Pursue New Opportunity, Effective May 12, 2023 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced that it has appointed Jay Matushak as the Company's next Chief Financial Officer, effective May 12, 2023. Mr. Matushak will succeed Cathy Smith, who is stepping down to pursue another opportunity. Mr. Matushak, a seasoned finance and operational executive with deep expertise in the healthcare business, joined Bright Health in 2021. He currently serves as Senior Vice President of Finance and is responsible

      5/3/23 5:00:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Announces Retirement of General Counsel Keith Nelsen

      Jeff Craig, lead counsel for the Company's NeueHealth business, named General Counsel and Corporate Secretary Bright Health Group, Inc. ("Bright Health" or "The Company") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that Keith Nelsen will retire as General Counsel and Corporate Secretary. Jeff Craig, lead counsel for the Company's NeueHealth business, will be promoted to the role of General Counsel and Corporate Secretary effective March 18, 2022. Nelsen will stay on as a senior advisor with the Company until June 30, 2022, to ensure a smooth transition. "Keith has been a key leader for many of our mi

      3/15/22 4:35:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Names Leading Healthcare Expert to Board

      Matthew Manders to Join as Independent Director Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that leading healthcare expert Matt Manders will join the company's Board as an independent director, effective March 1. Manders brings a wealth of diverse healthcare experience, focus on operational excellence, and expertise in consumer-driven healthcare. Most recently, he served as president of Cigna Corporation's Government and Solutions organization, part of a 30-plus-year career with the company. In this role, Manders led and managed Cigna's U.S. Government busi

      3/1/22 8:10:00 AM ET
      $BHG
      Medical Specialities
      Health Care